BSE Live
Dec 26, 16:01Prev. Close
1737.50
Open Price
1727.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 26, 15:54Prev. Close
1737.00
Open Price
1737.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1719.50 (503)
| Cash Flow of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 3,253.00 | 719.45 | 280.25 | -16.80 | -1,067.91 | |
| Net CashFlow From Operating Activities | 1,305.85 | 1,242.18 | -1,171.23 | -1,621.00 | -1,244.45 | |
| Net Cash Used In Investing Activities | 1,479.29 | 433.69 | 1,391.62 | 2,381.38 | 3,630.19 | |
| Net Cash Used From Financing Activities | -2,871.15 | -1,468.59 | -272.10 | -752.99 | -2,425.12 | |
| Foreign Exchange Gains / Losses | 3.75 | -2.32 | 1.99 | -0.86 | 0.52 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -82.26 | 204.96 | -49.72 | 6.53 | -38.86 | |
| Cash And Cash Equivalents Begin of Year | 302.76 | 97.80 | 147.52 | 140.99 | 193.20 | |
| Cash And Cash Equivalents End Of Year | 220.50 | 302.76 | 97.80 | 147.52 | 154.34 |
20.11.2025
12.11.2025
11.11.2025
Buy Sun Pharmaceutical Industries; target of Rs 1875 Prabhudas Lilladher
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend